Evoked Response Tests | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its evoked response tests coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.

CMS evoked response tests coverage policy governs how Medicare pays for diagnostic testing that measures the nervous system's electrical activity in response to stimulation. This modification affects neurology, audiology, and neurophysiology practices billing evoked potential studies to Medicare. The policy does not list specific codes in the available source data — we'll cover what that means for your team below.

Quick-Reference Table

CMS Evoked Response Tests Coverage Criteria and Medical Necessity Requirements 2026

Evoked response tests — also called evoked potentials — are diagnostic studies that measure how the brain and nervous system respond to specific stimuli. The main categories include visual evoked potentials (VEPs), brainstem auditory evoked responses (BAERs), somatosensory evoked potentials (SSEPs), and motor evoked potentials (MEPs). Each has its own clinical use case and, under this CMS coverage policy, its own set of medical necessity criteria.

CMS medical necessity requirements for evoked response tests have historically tied coverage to specific neurological conditions — things like suspected multiple sclerosis, spinal cord monitoring during surgery, hearing assessment in patients who can't respond to behavioral testing, and peripheral nerve damage evaluation. The modification effective May 15, 2026 signals a review of those criteria. Any time CMS touches a "Modified" designation on a policy like this, your billing team should treat it as a trigger to re-examine your documentation standards — not assume nothing changed.

The real issue here is that "modified" can mean anything from a minor technical edit to a substantive shift in coverage criteria. Because the policy source data does not include a full line-by-line summary of what changed, your first action should be to pull the actual policy document from the CMS website and compare it against whatever version your team has been working from. If you don't have a baseline version on file, that's a process gap worth fixing before May 15, 2026.

Prior authorization is not typically required for Medicare fee-for-service evoked response tests, but your Medicare Administrative Contractor (MAC) may have issued a local coverage determination (LCD) that adds requirements on top of the national policy. Check your MAC's LCD before assuming the national policy is your only constraint.

CMS Evoked Response Tests Exclusions and Non-Covered Indications

CMS has historically excluded evoked response tests when they're used for conditions where clinical evidence doesn't support diagnostic value. Screening use in asymptomatic patients — running an SSEP on someone with no neurological complaints — is a common denial trigger. So is ordering a VEP when the clinical record doesn't document a presenting condition that would make the test relevant.

Intraoperative neurophysiological monitoring (IONM) is a related but distinct billing category. If your practice does IONM, don't assume this evoked response modification automatically applies the same way. IONM has separate billing guidelines and reimbursement pathways that may or may not be touched by this update.

Routine screening and repeat testing without documented clinical indication are the two most common reasons CMS denies evoked response claims. If your documentation reads like a standing order rather than a clinically driven decision, you're at risk for claim denial regardless of how you code the service.

Coverage Indications at a Glance

Because the policy source data does not include a detailed indication-by-indication breakdown, the table below reflects the standard CMS coverage framework for evoked response tests based on the national policy structure. Confirm each row against the updated May 15, 2026 document before using this as your sole reference.

CMS Evoked Response Tests Billing Guidelines and Action Items 2026

1. Pull the updated policy document from CMS before May 15, 2026.
Don't rely on a summary — including this one. Go to the CMS source directly and read what changed. The effective date of May 15, 2026 is your hard deadline. If you're billing evoked response tests and haven't reviewed the updated text, you're flying blind.

2. Compare your current documentation templates against the updated medical necessity criteria.
Whatever CMS changed, your documentation has to match it. If the criteria tightened, your order forms, clinical notes, and attestations need to reflect the new standard before the first claim goes out under the new policy.

3. Check your MAC's LCD for regional variations.
The national CMS policy sets the floor. Your MAC may have a local coverage determination that's more restrictive. Pull the LCD from your specific MAC and make sure your billing guidelines account for both layers of coverage policy.

4. Audit your evoked response claims from the last 12 months.
Look for patterns that would put you at risk under a modified policy — missing clinical indications, repeat testing without documented rationale, or services billed without a covered diagnosis. Fix your processes now, before claim denial volume tells you something went wrong.

5. Train your ordering providers on the updated criteria.
Billing teams can't fix a denial that starts with a poorly documented order. Make sure the neurologists, physiatrists, and audiologists ordering these tests understand what the updated medical necessity criteria require. A one-page summary of the new requirements, shared before May 15, 2026, saves you significant rework later.

6. Confirm your charge capture reflects current coding.
The policy source data does not list specific CPT or HCPCS codes. This makes it especially important to verify that your charge master and charge capture tools are mapped to the right codes and that your billing guidelines align with whatever coding the updated policy references. If you're not sure which codes fall under this policy, loop in your compliance officer before the effective date.

7. Flag high-volume accounts for a pre-billing review.
If evoked response testing is a significant part of your revenue mix — particularly in neurophysiology or audiology practices — consider a targeted pre-bill review for the first 30 days after May 15, 2026. Catching a documentation gap before a claim goes out is far cheaper than working a denial.

CPT, HCPCS, and ICD-10 Codes for Evoked Response Tests Under This CMS Policy

The policy source data provided for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for a CMS national policy update — the code-level detail often lives in the LCD issued by individual MACs rather than in the national document itself.

Do not assume the absence of codes here means the policy doesn't affect specific codes. Evoked response tests billing typically involves a set of well-established CPT codes that have been part of this coverage policy historically. Pull the full policy document and your MAC's LCD to confirm exactly which codes are in scope.

When you do, pay attention to whether the modification changed the covered diagnoses, the technical versus professional component billing rules, or the frequency limitations. Those are the three areas where a "modified" designation most commonly shows up as a real change in how claims process — and where reimbursement exposure is highest if your documentation doesn't keep pace.

If you need a starting point for which CPT codes are historically associated with evoked response tests under Medicare, your MAC's LCD is the definitive source. That document will list covered codes, covered diagnoses, and any frequency or coverage limitations specific to your region.